John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$166M |
| 2 |
General Motors
GM
|
+$156M |
| 3 |
Union Pacific
UNP
|
+$154M |
| 4 |
Pfizer
PFE
|
+$124M |
| 5 |
McDonald's
MCD
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$132M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$124M |
| 3 |
Liberty Global Class A
LBTYA
|
+$120M |
| 4 |
Freeport-McMoran
FCX
|
+$110M |
| 5 |
Vodafone
VOD
|
+$80.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.69% |
| 2 | Healthcare | 12.24% |
| 3 | Technology | 11.21% |
| 4 | Energy | 10.78% |
| 5 | Financials | 10.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Wheaton Precious Metals
WPM
$71.7B
| $5.07M | 0.03% |
204,823
+175,007
| +587% | +$4.16M |
|
527
Cinemark Holdings
CNK
$4.24B
| $5.07M | 0.03% |
159,754
-105,170
| -40% | -$3.16M |
|
|
FTR
528
DELISTED
Frontier Communications Corp.
FTR
| $5.05M | 0.03% |
80,755
+64,272
| +390% | +$4.18M |
|
529
Ionis Pharmaceuticals
IONS
$9.93B
| $5.03M | 0.03% |
+134,081
| New | +$4.01M |
|
530
Extreme Networks
EXTR
$3B
| $5.02M | 0.03% |
961,029
+584,799
| +155% | +$2.38M |
|
|
SYA
531
DELISTED
SYMETRA FINANCIAL CORPORATION COMMON STOCK
SYA
| $5.01M | 0.03% |
281,146
+118,349
| +73% | +$2.11M |
|
|
PWRD
532
DELISTED
PERFECT WORLD CO LTD SPONSORED ADR REPSTG CL B (CAYMAN ISL)
PWRD
| $5M | 0.03% |
251,522
-129,207
| -34% | -$2.63M |
|
|
SREV
533
DELISTED
ServiceSource International, Inc.
SREV
| $5M | 0.03% |
413,507
+369,070
| +831% | +$4.36M |
|
|
CELG
534
DELISTED
Celgene Corp
CELG
| $4.99M | 0.03% |
64,872
-303,294
| -82% | -$21.3M |
|
|
NXGN
535
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $4.94M | 0.03% |
227,249
+179,722
| +378% | +$3.84M |
|
536
Parker-Hannifin
PH
$126B
| $4.93M | 0.03% |
+45,364
| New | +$4.67M |
|
|
NRF
537
DELISTED
NorthStar Realty Finance Corp.
NRF
| $4.93M | 0.03% |
270,545
-374,282
| -58% | -$6.82M |
|
538
OSI Systems
OSIS
$3.41B
| $4.88M | 0.03% |
65,565
+52,875
| +417% | +$3.75M |
|
539
iShares S&P 500 Growth ETF
IVW
$76.1B
| $4.88M | 0.03% |
+218,288
| New | +$4.82M |
|
540
Prestige Consumer Healthcare
PBH
$2.43B
| $4.85M | 0.03% |
161,013
+153,340
| +1,998% | +$5.01M |
|
541
Walmart Inc
WMT
$825B
| $4.81M | 0.03% |
+195,099
| New | +$4.92M |
|
542
Travelers Companies
TRV
$75.8B
| $4.77M | 0.03% |
+56,259
| New | +$4.65M |
|
543
Molson Coors Class B
TAP
$8.01B
| $4.75M | 0.03% |
94,753
-156,437
| -62% | -$7.87M |
|
544
LKQ Corp
LKQ
$6.52B
| $4.71M | 0.03% |
147,726
+132,712
| +884% | +$3.83M |
|
545
Benchmark Electronics
BHE
$2.61B
| $4.68M | 0.03% |
204,457
-5,663
| -3% | -$125K |
|
546
Hershey
HSY
$37.5B
| $4.63M | 0.03% |
50,088
-75,826
| -60% | -$7.07M |
|
|
BEL
547
DELISTED
Belmond Ltd.
BEL
| $4.62M | 0.03% |
355,561
-72,260
| -17% | -$906K |
|
|
FRGI
548
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $4.6M | 0.03% |
122,142
+82,614
| +209% | +$2.8M |
|
549
Markel Group
MKL
$22.2B
| $4.56M | 0.03% |
8,815
-11,989
| -58% | -$6.3M |
|
|
WBS
550
DELISTED
Webster Financial
WBS
| $4.53M | 0.03% |
177,309
-77,472
| -30% | -$2.06M |
|
Similar funds
John Overdeck's Q3 2013 Portfolio in Review
As of Q3 2013, John Overdeck held 2,423 positions worth $15.7B, up 9.6% from $14.3B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
John Overdeck deployed $511M of net new capital in Q3 2013, opening 482 new positions and adding to 549 existing holdings. Its largest new stake was Johnson & Johnson: 1,855,436 shares worth $161M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was EMC CORPORATION, an estimated $124M trimmed.
- John Overdeck's largest Q3 2013 buy was Johnson & Johnson: 1,855,436 shares worth $161M.
- John Overdeck added most to Alphabet (Google) Class C in Q3 2013, an estimated $100M increase.
- John Overdeck's biggest Q3 2013 reduction was EMC CORPORATION, cutting an estimated $124M.
- John Overdeck fully exited IBM in Q3 2013, selling an estimated $132M.
- John Overdeck's ten largest holdings make up 9.4% of its $15.7B portfolio in Q3 2013.
- John Overdeck opened 482 new positions and closed 621 in Q3 2013.
- John Overdeck's portfolio value rose 9.6% quarter-over-quarter to $15.7B.
Based on Two Sigma Investments's 13F filing for Q3 2013, filed 14 Nov 2013.